Title: Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma.
Citation: Biomedicines
2021;9:1550.
Country: Italy | Indication: Asthma
Scan to access the publication or visit
http://tago.ca/34829778
http://tago.ca/34829778